Table 2.
Vaccine | Sessions with at Least One Beneficiary | Median (IQR) * | |
---|---|---|---|
n | (%) * | ||
BCG | 378 | (38.2) | 6 (2–8) |
Pentavalent | 887 | (89.6) | 5 (2–9) |
OPV | 887 | (89.6) | 5 (2–9) |
IPV | 665 | (67.2) | 2 (1–4) |
PCV | 887 | (89.6) | 5 (2–9) |
MR | 688 | (69.5) | 4 (2–8) |
JE | 566 | (57.2) | 3 (1–5) |
Hep B | 12 | (1.2) | 9 (8–12) |
Td | 794 | (80.2) | 4 (2–7) |
* Proportion and median calculated with 990 sessions as the denominator. Abbreviations: EPI, Expanded Programme on Immunization; BCG, Bacillus Calmette–Guérin; OPV, oral polio vaccine; IPV, injectable polio vaccine; PCV, pneumococcal conjugate vaccine; MR, measles–rubella; JE, Japanese encephalitis; Td, tetanus–diphtheria; Hep B, hepatitis B.